Benkowitz Michael's Form 4 filing
United Therapeutics Corp (UTHR) · filed Feb 19, 2025
- Accession no.
- 0001562180-25-001348
- Filed
- Feb 19, 2025
- Trade date
- Feb 18, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.71M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benkowitz MichaelCIK 0001673232 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Stock | MOption exerciseAcquired | +7,500 | $111.00 | +$832,500 | 7,500 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −100 | $366.19 | −$36,619 | 7,400 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −600 | $368.32 | −$220,992 | 6,800 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −1,432 | $369.65 | −$529,338.8 | 5,368 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −1,068 | $370.70 | −$395,907.6 | 4,300 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −2,351 | $371.47 | −$873,325.97 | 1,949 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −1,549 | $372.63 | −$577,203.87 | 400 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −400 | $373.67 | −$149,468 | 0 | Indirect | |
| Feb 18, 2025 | Common Stock | MOption exerciseAcquired | +2,500 | $111.00 | +$277,500 | 2,500 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −200 | $367.97 | −$73,594 | 2,300 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −500 | $369.43 | −$184,715 | 1,800 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −601 | $370.85 | −$222,880.85 | 1,199 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −600 | $371.67 | −$223,002 | 599 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −499 | $372.82 | −$186,037.18 | 100 | Indirect | |
| Feb 18, 2025 | Common Stock | SSaleDisposed | −100 | $374.18 | −$37,418 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 14,679 | Indirect | |
| Feb 18, 2025 | Common Stock | MOption exerciseDisposed | −2,500 | $0.00 | $0 | 7,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.